Anaplastic Plasmacytoma - 362 Studies Found Terminated : Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders : Multiple Myeloma and Plasma Cell Neoplasm : 2005-11-22 : Drug: paricalcitol Drug: zoledronic acid Completed : Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia : Multiple Myeloma and Plasma Cell Neoplasm : 2005-11-22 : Dietary Supplement: ascorbic acid Completed : Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2005-11-22 : Biological: rituximab Other Na Terminated : Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2005-09-26 : Dietary Supplement: ascorbic acid Drug: ar Withdrawn : Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma : Stage I Multiple Myeloma Stage II Multiple Myeloma Stage I : 2005-06-02 : Drug: arsenic trioxide Drug: ascorbic acid Withdrawn : Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma : Stage II Multiple Myeloma Stage III Multiple Myeloma Refra : 2004-06-10 : Drug: arsenic trioxide Drug: ascorbic acid Completed : Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2004-06-10 : Drug: bortezomib Completed : S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma : Multiple Myeloma Plasma Cell Neoplasm : 2003-07-08 : Drug: dexamethasone Given oral Completed : Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2003-05-06 : Drug: brostallicin Patients receive brostallicin IV over 1 Completed : Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2003-02-05 : Drug: dexamethasone Drug: doxorubicin hydr <<< Previous | Next >>>